Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10°9 pfu/ml vector genomes, per 0.1 ml
PULASKI, VA
See all hospitals reporting HCPCS J3401 →Price type
Lewisgale Hospital Pulaski’s median price of $890 is 22% below the median hospital's median price ($1.1k), higher than 1% of the 1,095 hospitals reporting HCPCS J3401. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Negotiated rates from the hospital’s own file: 2 payers, 2 plan rates. A facility fee, a professional fee, a per diem and a case rate are different bills, so each is listed on its own. Open a payer to see it across hospitals.
Filter by billing methodology
Filter by billing class
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | Humana trcr fee schedule · outpatient | $763 | $763 | — | — | — | $763 – $763 |
| 2 | UnitedHealthcare allpayerappendix fee schedule · outpatient | $2.7k | $2.7k | — | — | — | $2.7k – $2.7k |
Last updated: Mar 7, 2026
See Topical gene therapy product, per 0.1 mL pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.